NantKwest, Inc. (NK) Given Consensus Rating of “Hold” by Analysts
NantKwest, Inc. (NASDAQ:NK) has earned a consensus recommendation of “Hold” from the six analysts that are currently covering the stock, Marketbeat.com reports. Three research analysts have rated the stock with a sell recommendation, one has issued a hold recommendation and two have given a buy recommendation to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $5.44.
Several equities research analysts have issued reports on the company. BidaskClub lowered NantKwest from a “sell” rating to a “strong sell” rating in a research note on Friday, September 22nd. Zacks Investment Research raised NantKwest from a “hold” rating to a “buy” rating and set a $5.75 price target for the company in a research note on Wednesday. Citigroup Inc. set a $3.00 price target on NantKwest and gave the stock a “sell” rating in a research note on Monday, August 14th. Finally, ValuEngine raised NantKwest from a “strong sell” rating to a “sell” rating in a research note on Wednesday, June 14th.
NantKwest (NASDAQ NK) opened at 5.12 on Wednesday. The firm’s market cap is $406.73 million. The firm has a 50-day moving average price of $5.56 and a 200-day moving average price of $5.56. NantKwest has a one year low of $4.35 and a one year high of $7.95.
COPYRIGHT VIOLATION NOTICE: “NantKwest, Inc. (NK) Given Consensus Rating of “Hold” by Analysts” was first reported by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another domain, it was illegally copied and reposted in violation of U.S. and international copyright law. The legal version of this news story can be accessed at https://www.americanbankingnews.com/2017/10/11/nantkwest-inc-nk-given-consensus-rating-of-hold-by-analysts.html.
In other news, Director Steve Gorlin sold 39,604 shares of the business’s stock in a transaction dated Wednesday, September 13th. The stock was sold at an average price of $5.93, for a total value of $234,851.72. Following the completion of the sale, the director now owns 246,280 shares of the company’s stock, valued at approximately $1,460,440.40. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 70.19% of the company’s stock.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in NK. Nisa Investment Advisors LLC bought a new stake in shares of NantKwest in the 2nd quarter valued at about $100,000. Voya Investment Management LLC purchased a new position in NantKwest during the 2nd quarter valued at about $102,000. Gotham Asset Management LLC purchased a new position in NantKwest during the 2nd quarter valued at about $104,000. Dynamic Technology Lab Private Ltd increased its holdings in NantKwest by 53.4% during the 1st quarter. Dynamic Technology Lab Private Ltd now owns 32,939 shares of the biotechnology company’s stock valued at $117,000 after purchasing an additional 11,465 shares during the period. Finally, Alliancebernstein L.P. increased its holdings in NantKwest by 8.7% during the 1st quarter. Alliancebernstein L.P. now owns 33,800 shares of the biotechnology company’s stock valued at $120,000 after purchasing an additional 2,700 shares during the period. 18.79% of the stock is owned by institutional investors.
Receive News & Ratings for NantKwest Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantKwest Inc. and related companies with MarketBeat.com's FREE daily email newsletter.